New hope for men suffering hot flashes from prostate cancer treatment
NCT ID NCT07568236
First seen May 06, 2026 · Last updated May 17, 2026 · Updated 2 times
Summary
This study tests whether fezolinetant can reduce hot flashes in men with prostate cancer who are on hormone therapy (ADT). About 54 men will be randomly assigned to receive the drug or a placebo. The main goal is to see if the drug lowers the frequency and severity of hot flashes and improves quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Prince of Wales Hospital
Shatin, Hong Kong
Conditions
Explore the condition pages connected to this study.